{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T03:43:02Z","timestamp":1791776582138,"version":"4.3.4"},"reference-count":103,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2022,12,5]],"date-time":"2022-12-05T00:00:00Z","timestamp":1670198400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2022,12,5]],"date-time":"2022-12-05T00:00:00Z","timestamp":1670198400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/100004331","name":"Johnson and Johnson","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004331","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Pediatr"],"DOI":"10.1007\/s00431-022-04724-0","type":"journal-article","created":{"date-parts":[[2022,12,5]],"date-time":"2022-12-05T00:05:31Z","timestamp":1670198731000},"page":"489-500","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":42,"title":["History and current standard of postnatal management in hemolytic disease of the fetus and newborn"],"prefix":"10.1007","volume":"182","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4820-143X","authenticated-orcid":false,"given":"Derek P","family":"De Winter","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8159-7501","authenticated-orcid":false,"given":"Christian","family":"Hulzebos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8981-9500","authenticated-orcid":false,"given":"Renske M","family":"Van \u2018t Oever","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7044-0525","authenticated-orcid":false,"given":"Masja","family":"De Haas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9343-9957","authenticated-orcid":false,"given":"EJT","family":"Verweij","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3513-5066","authenticated-orcid":false,"given":"Enrico","family":"Lopriore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,12,5]]},"reference":[{"key":"4724_CR1","unstructured":"Bourgeois L Observations diverses sur la st\u00e9rilit\u00e9, perte de fruicts, foecondit\u00e9, accouchements, et maladies des femmes et enfants nouveaux naiz amplement traitt\u00e9es heureusement praticqu\u00e9es. 1617, Paris: A. Saugrain"},{"issue":"3","key":"4724_CR2","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1016\/S0022-3476(32)80057-0","volume":"1","author":"LK Diamond","year":"1932","unstructured":"Diamond LK, Blackfan KD, Baty JM (1932) Erythroblastosis fetalis and its association with universal edema of the fetus, icterus gravis neonatorum and anemia of the newborn. J Pediatr 1(3):269\u2013309","journal-title":"J Pediatr"},{"issue":"20\u201321","key":"4724_CR3","first-page":"768","volume":"113","author":"K Landsteiner","year":"2001","unstructured":"Landsteiner K (2001) Agglutination phenomena of normal human blood. Wien Klin Wochenschr 113(20\u201321):768\u20139","journal-title":"Wien Klin Wochenschr"},{"issue":"1","key":"4724_CR4","doi-asserted-by":"publisher","first-page":"223","DOI":"10.3181\/00379727-43-11151","volume":"43","author":"K Landsteiner","year":"1940","unstructured":"Landsteiner K, Wiener AS (1940) An agglutinable factor in human blood recognized by immune sera for Rhesus blood. Proceedings of the Society for Experimental Biology and Medicine 43(1):223\u2013223","journal-title":"Proceedings of the Society for Experimental Biology and Medicine"},{"issue":"10","key":"4724_CR5","doi-asserted-by":"publisher","first-page":"1316","DOI":"10.1001\/jama.1984.03340340056028","volume":"251","author":"P Levine","year":"1984","unstructured":"Levine P, Stetson RE (1984) An unusual case of intra-group agglutination. JAMA 251(10):1316\u20131317","journal-title":"JAMA"},{"issue":"5238","key":"4724_CR6","doi-asserted-by":"publisher","first-page":"1486","DOI":"10.1136\/bmj.1.5238.1486","volume":"1","author":"R Finn","year":"1961","unstructured":"Finn R et al (1961) Experimental studies on the prevention of Rh haemolytic disease. Br Med J 1(5238):1486\u201390","journal-title":"Br Med J"},{"key":"4724_CR7","doi-asserted-by":"crossref","unstructured":"Stern K, Goodman HS, Berger M (1975)\u00a0Isoimmunization Experimental, to hemoantigens in man, in Rhesus haemolytic disease: selected papers and extracts, Clarke CA (eds) \u00a0Springer. Dordrecht, Netherlands, pp 161\u2013169","DOI":"10.1007\/978-94-011-6138-1_28"},{"issue":"5336","key":"4724_CR8","doi-asserted-by":"publisher","first-page":"979","DOI":"10.1136\/bmj.1.5336.979","volume":"1","author":"CA Clarke","year":"1963","unstructured":"Clarke CA et al (1963) Further experimental studies on the prevention of Rh haemolytic disease. Br Med J 1(5336):979\u201384","journal-title":"Br Med J"},{"issue":"1","key":"4724_CR9","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1111\/j.1537-2995.1964.tb02824.x","volume":"4","author":"VJ Freda","year":"1964","unstructured":"Freda VJ, Gorman JG, Pollack W (1964) Successful prevention of experimental Rh sensitization in man with an anti-Rh gamma2-globulin antibody preparation: a preliminary report. Transfusion 4(1):26\u201332","journal-title":"Transfusion"},{"issue":"3","key":"4724_CR10","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1111\/trf.16276","volume":"61","author":"JS Luken","year":"2021","unstructured":"Luken JS et al (2021) Reduction of anti-K-mediated hemolytic disease of newborns after the introduction of a matched transfusion policy: a nation-wide policy change evaluation study in the Netherlands. Transfusion 61(3):713\u2013721","journal-title":"Transfusion"},{"issue":"2","key":"4724_CR11","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1111\/vox.12265","volume":"109","author":"M De Haas","year":"2015","unstructured":"De Haas M et al (2015) Haemolytic disease of the fetus and newborn. Vox Sang 109(2):99\u2013113","journal-title":"Vox Sang"},{"issue":"6","key":"4724_CR12","doi-asserted-by":"publisher","first-page":"1359","DOI":"10.1016\/S0002-9378(16)36265-2","volume":"82","author":"AW Liley","year":"1961","unstructured":"Liley AW (1961) Liquor amnii analysis in the management of the pregnancy complicated by Rhesus sensitization. A J Obstet Gynecol 82(6):1359\u20131370","journal-title":"A J Obstet Gynecol"},{"issue":"5365","key":"4724_CR13","doi-asserted-by":"publisher","first-page":"1107","DOI":"10.1136\/bmj.2.5365.1107","volume":"2","author":"AW Liley","year":"1963","unstructured":"Liley AW (1963) Intrauterine transfusion of foetus in haemolytic disease. Br Med J 2(5365):1107\u20139","journal-title":"Br Med J"},{"issue":"6","key":"4724_CR14","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1016\/0002-9378(84)90683-5","volume":"150","author":"CH Rodeck","year":"1984","unstructured":"Rodeck CH et al (1984) The management of severe Rhesus isoimmunization by fetoscopic intravascular transfusions. Am J Obstet Gynecol 150(6):769\u201374","journal-title":"Am J Obstet Gynecol"},{"key":"4724_CR15","doi-asserted-by":"crossref","unstructured":"Mari G et al (2000) Noninvasive diagnosis by Doppler ultrasonography of fetal anemia due to maternal red-cell alloimmunization. Collaborative Group for Doppler Assessment of the Blood Velocity in Anemic Fetuses. N Engl J Med\u00a0342(1):9\u201314","DOI":"10.1097\/00006254-200006000-00005"},{"issue":"2","key":"4724_CR16","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1056\/NEJMoa052855","volume":"355","author":"D Oepkes","year":"2006","unstructured":"Oepkes D et al (2006) Doppler ultrasonography versus amniocentesis to predict fetal anemia. New Engl J Med 355(2):156\u2013164","journal-title":"New Engl J Med"},{"issue":"2680","key":"4724_CR17","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1126\/science.103.2680.583","volume":"103","author":"H Wallerstein","year":"1946","unstructured":"Wallerstein H (1946) Treatment of severe erythroblastosis by simultaneous removal and replacement of the blood of the newborn infant. Science 103(2680):583","journal-title":"Science"},{"key":"4724_CR18","unstructured":"Cremer RJ, PWP, Richards DH, Holbrook B, Biochem J (1957).\u00a066:60P"},{"issue":"7030","key":"4724_CR19","doi-asserted-by":"publisher","first-page":"1094","DOI":"10.1016\/S0140-6736(58)91849-X","volume":"271","author":"RJ Cremer","year":"1958","unstructured":"Cremer RJ, Perryman PW, Richards DH (1958) Influence of light on the hyperbilirubin\u00e6mia of infants. Lancet 271(7030):1094\u20131097","journal-title":"Lancet"},{"issue":"4","key":"4724_CR20","doi-asserted-by":"publisher","first-page":"644","DOI":"10.1542\/peds.46.4.644","volume":"46","author":"SW Fong","year":"1970","unstructured":"Fong SW, Margolis AJ (1970) Letter to the editor. Pediatrics 46(4):644\u2013644","journal-title":"Pediatrics"},{"issue":"6","key":"4724_CR21","doi-asserted-by":"publisher","first-page":"1047","DOI":"10.1542\/peds.41.6.1047","volume":"41","author":"J Lucey","year":"1968","unstructured":"Lucey J, Ferreiro M, Hewitt J (1968) Prevention of hyperbilirubinemia of prematurity by phototherapy. Pediatrics 41(6):1047\u20131054","journal-title":"Pediatrics"},{"issue":"6","key":"4724_CR22","doi-asserted-by":"publisher","first-page":"1032","DOI":"10.1542\/peds.2012-3651","volume":"131","author":"EM Weiss","year":"2013","unstructured":"Weiss EM, Zimmerman SS (2013) A tale of two hospitals: the evolution of phototherapy treatment for neonatal jaundice. Pediatrics 131(6):1032\u20131034","journal-title":"Pediatrics"},{"issue":"12","key":"4724_CR23","doi-asserted-by":"publisher","first-page":"798","DOI":"10.1056\/NEJM199803193381204","volume":"338","author":"JI Vaughan","year":"1998","unstructured":"Vaughan JI et al (1998) Inhibition of erythroid progenitor cells by anti-Kell antibodies in fetal alloimmune anemia. New Engl J Med 338(12):798\u2013803","journal-title":"New Engl J Med"},{"issue":"4","key":"4724_CR24","doi-asserted-by":"publisher","first-page":"643","DOI":"10.7705\/biomedica.5930","volume":"41","author":"M P\u00e1ez","year":"2021","unstructured":"P\u00e1ez M, Jim\u00e9nez M, Corredor A (2021) Hemolytic disease in fetuses and newborns due to antibodies against the M-antigen. Biomedica 41(4):643\u2013650","journal-title":"Biomedica"},{"issue":"6","key":"4724_CR25","doi-asserted-by":"publisher","first-page":"1908","DOI":"10.1111\/trf.16350","volume":"61","author":"S Li","year":"2021","unstructured":"Li S et al (2021) Hyporegenerative anemia in anti-M-associated hemolytic disease of the fetus. Transfusion 61(6):1908\u20131915","journal-title":"Transfusion"},{"issue":"10","key":"4724_CR26","doi-asserted-by":"crossref","first-page":"2152","DOI":"10.1111\/trf.12027","volume":"53","author":"LL Pate","year":"2013","unstructured":"Pate LL et al (2013) Anti-Ge3 causes late-onset hemolytic disease of the newborn: the fourth case in three Hispanic families. Transfusion 53(10):2152\u20137","journal-title":"Transfusion"},{"issue":"5","key":"4724_CR27","doi-asserted-by":"publisher","DOI":"10.1016\/j.transci.2020.102949","volume":"59","author":"H Ohto","year":"2020","unstructured":"Ohto H et al (2020) Three non-classical mechanisms for anemic disease of the fetus and newborn, based on maternal anti-Kell, anti-Ge3, anti-M, and anti-Jr(a) cases. Transfus Apher Sci 59(5):102949","journal-title":"Transfus Apher Sci"},{"issue":"3","key":"4724_CR28","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1111\/j.1423-0410.1988.tb03897.x","volume":"54","author":"PT Toy","year":"1988","unstructured":"Toy PT et al (1988) Prevalence of ABO maternal-infant incompatibility in Asians, Blacks. Hispanics and Caucasians. Vox Sang 54(3):181\u20133","journal-title":"Hispanics and Caucasians. Vox Sang"},{"issue":"2","key":"4724_CR29","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1111\/j.1423-0410.1995.tb02569.x","volume":"68","author":"M Lin","year":"1995","unstructured":"Lin M, Broadberry RE (1995) ABO hemolytic disease of the newborn is more severe in Taiwan than in White populations. Vox Sang 68(2):136\u2013136","journal-title":"Vox Sang"},{"issue":"2","key":"4724_CR30","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1179\/2046905512Y.0000000002","volume":"32","author":"YR Bhat","year":"2012","unstructured":"Bhat YR, Kumar CG (2012) Morbidity of ABO haemolytic disease in the newborn. Paediatr Int Child Health 32(2):93\u20136","journal-title":"Paediatr Int Child Health"},{"issue":"1","key":"4724_CR31","first-page":"35","volume":"24","author":"P Han","year":"1988","unstructured":"Han P et al (1988) Haematolytic disease due to ABO incompatibility: incidence and value of screening in an Asian population. Aust Paediatr J 24(1):35\u20138","journal-title":"Aust Paediatr J"},{"key":"4724_CR32","doi-asserted-by":"crossref","unstructured":"Van \u2019t Oever RM et al (2022)\u00a0Identification and management of fetal anemia due to hemolytic disease. Expert Rev Hematol 1\u201312","DOI":"10.1080\/17474086.2022.2138853"},{"issue":"5","key":"4724_CR33","doi-asserted-by":"publisher","first-page":"1015","DOI":"10.1067\/mob.2001.112970","volume":"184","author":"D Oepkes","year":"2001","unstructured":"Oepkes D et al (2001) Clinical value of an antibody-dependent cell-mediated cytotoxicity assay in the management of Rh D alloimmunization. Am J Obstet Gynecol 184(5):1015\u201320","journal-title":"Am J Obstet Gynecol"},{"issue":"2","key":"4724_CR34","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1111\/trf.15631","volume":"60","author":"JM Koelewijn","year":"2020","unstructured":"Koelewijn JM et al (2020) Diagnostic value of laboratory monitoring to predict severe hemolytic disease of the fetus and newborn in non-D and non-K-alloimmunized pregnancies. Transfusion 60(2):391\u2013399","journal-title":"Transfusion"},{"issue":"2","key":"4724_CR35","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1056\/NEJMoa052855","volume":"355","author":"D Oepkes","year":"2006","unstructured":"Oepkes D et al (2006) Doppler ultrasonography versus amniocentesis to predict fetal anemia. N Engl J Med 355(2):156\u201364","journal-title":"N Engl J Med"},{"issue":"2","key":"4724_CR36","doi-asserted-by":"publisher","first-page":"141.e1","DOI":"10.1016\/j.ajog.2011.09.024","volume":"206","author":"IT Lindenburg","year":"2012","unstructured":"Lindenburg IT et al (2012) Long-term neurodevelopmental outcome after intrauterine transfusion for hemolytic disease of the fetus\/newborn: the LOTUS study. Am J Obstet Gynecol 206(2):141.e1\u20138","journal-title":"Am J Obstet Gynecol"},{"key":"4724_CR37","doi-asserted-by":"publisher","DOI":"10.1155\/2012\/985646","volume":"2012","author":"P Palmeira","year":"2012","unstructured":"Palmeira P et al (2012) IgG placental transfer in healthy and pathological pregnancies. Clin Dev Immunol 2012:985646","journal-title":"Clin Dev Immunol"},{"issue":"3","key":"4724_CR38","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2015-3236","volume":"137","author":"C Garabedian","year":"2016","unstructured":"Garabedian C et al (2016) Benefits of delayed cord clamping in red blood cell alloimmunization. Pediatrics 137(3):e20153236","journal-title":"Pediatrics"},{"issue":"3","key":"4724_CR39","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1111\/j.1423-0410.2011.01539.x","volume":"102","author":"ME Rath","year":"2012","unstructured":"Rath ME et al (2012) Thrombocytopenia at birth in neonates with red cell alloimmune haemolytic disease. Vox Sang 102(3):228\u201333","journal-title":"Vox Sang"},{"key":"4724_CR40","doi-asserted-by":"crossref","unstructured":"Lai NM et al (2017) Fluid supplementation for neonatal unconjugated hyperbilirubinaemia. Cochrane Database Syst Rev\u00a08(8):Cd011891","DOI":"10.1002\/14651858.CD011891.pub2"},{"key":"4724_CR41","doi-asserted-by":"publisher","unstructured":"Kemper AR, Newman TB, Slaughter JL, Maisels MJ, Watchko JF, Downs SM, Grout RW, Bundy DG, Stark AR, Bogen DL, Holmes AV, Feldman-Winter LB, Bhutani VK, Brown S R, Maradiaga Panayotti GM, Okechukwu K, Rappo PD, Russell TL (2022) Clinical Practice Guideline Revision: Management of Hyperbilirubinemia in the Newborn Infant 35 or More Weeks of Gestation. Pediatrics 150(3):e2022058859. https:\/\/doi.org\/10.1542\/peds.2022-058859","DOI":"10.1542\/peds.2022-058859"},{"issue":"2","key":"4724_CR42","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1038\/sj.jp.7210862","volume":"23","author":"DS Seidman","year":"2003","unstructured":"Seidman DS et al (2003) A prospective randomized controlled study of phototherapy using blue and blue-green light-emitting devices, and conventional halogen-quartz phototherapy. J Perinatol 23(2):123\u20137","journal-title":"J Perinatol"},{"issue":"6","key":"4724_CR43","first-page":"771","volume":"136","author":"DS Seidman","year":"2000","unstructured":"Seidman DS et al (2000) A new blue light-emitting phototherapy device: a prospective randomized controlled study. J Pediatr 136(6):771\u20134","journal-title":"J Pediatr"},{"issue":"9","key":"4724_CR44","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1038\/sj.jp.7211789","volume":"27","author":"MJ Maisels","year":"2007","unstructured":"Maisels MJ, Kring EA, DeRidder J (2007) Randomized controlled trial of light-emitting diode phototherapy. J Perinatol 27(9):565\u20137","journal-title":"J Perinatol"},{"issue":"2","key":"4724_CR45","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1007\/s13312-010-0020-7","volume":"47","author":"P Kumar","year":"2010","unstructured":"Kumar P et al (2010) Light emitting diodes versus compact fluorescent tubes for phototherapy in neonatal jaundice: a multi center randomized controlled trial. Indian Pediatr 47(2):131\u20137","journal-title":"Indian Pediatr"},{"issue":"5","key":"4724_CR46","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1111\/j.1651-2227.2011.02561.x","volume":"101","author":"A Tridente","year":"2012","unstructured":"Tridente A, De Luca D (2012) Efficacy of light-emitting diode versus other light sources for treatment of neonatal hyperbilirubinemia: a systematic review and meta-analysis. Acta Paediatrica 101(5):458\u2013465","journal-title":"Acta Paediatrica"},{"key":"4724_CR47","doi-asserted-by":"crossref","unstructured":"Lozada LE et al (2015) Association of autism spectrum disorders with neonatal hyperbilirubinemia. Glob Pediatr Health\u00a02:2333794x15596518","DOI":"10.1177\/2333794X15596518"},{"issue":"5","key":"4724_CR48","first-page":"441","volume":"4","author":"S Cnattingius","year":"1995","unstructured":"Cnattingius S et al (1995) Prenatal and neonatal risk factors for childhood myeloid leukemia. Cancer Epidemiol Biomarkers Prev 4(5):441\u20135","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"4724_CR49","doi-asserted-by":"crossref","unstructured":"Wickremasinghe AC et al (2016)\u00a0Neonatal phototherapy and infantile cancer. Pediatrics\u00a0137(6)","DOI":"10.1542\/peds.2015-1353"},{"issue":"1","key":"4724_CR50","doi-asserted-by":"publisher","first-page":"247","DOI":"10.2337\/diacare.26.1.247-a","volume":"26","author":"G Dahlquist","year":"2003","unstructured":"Dahlquist G, Kallen B (2003) Indications that phototherapy is a risk factor for insulin-dependent diabetes. Diabetes Care 26(1):247\u20138","journal-title":"Diabetes Care"},{"key":"4724_CR51","doi-asserted-by":"crossref","unstructured":"Newman TB et al (2018) Childhood seizures after phototherapy. Pediatrics\u00a0142(4)","DOI":"10.1542\/peds.2018-0648"},{"issue":"1","key":"4724_CR52","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1111\/pai.12281","volume":"26","author":"RR Das","year":"2015","unstructured":"Das RR, Naik SS (2015) Neonatal hyperbilirubinemia and childhood allergic diseases: a systematic review. Pediatr Allergy Immunol 26(1):2\u201311","journal-title":"Pediatr Allergy Immunol"},{"issue":"6","key":"4724_CR53","doi-asserted-by":"publisher","first-page":"628","DOI":"10.1136\/archdischild-2019-317024","volume":"105","author":"LWE van der Schoor","year":"2020","unstructured":"van der Schoor LWE et al (2020) Blue LED phototherapy in preterm infants: effects on an oxidative marker of DNA damage. Arch Dis Child Fetal Neonatal Ed 105(6):628\u2013633","journal-title":"Arch Dis Child Fetal Neonatal Ed"},{"issue":"3","key":"4724_CR54","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1111\/j.1423-0410.2010.01408.x","volume":"100","author":"ME Rath","year":"2011","unstructured":"Rath ME et al (2011) Exchange transfusions and top-up transfusions in neonates with Kell haemolytic disease compared to Rh D haemolytic disease. Vox Sang 100(3):312\u20136","journal-title":"Vox Sang"},{"issue":"8","key":"4724_CR55","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1038\/jp.2014.66","volume":"34","author":"GF Tidmarsh","year":"2014","unstructured":"Tidmarsh GF, Wong RJ, Stevenson DK (2014) End-tidal carbon monoxide and hemolysis. J Perinatol 34(8):577\u2013581","journal-title":"J Perinatol"},{"issue":"10","key":"4724_CR56","doi-asserted-by":"publisher","first-page":"1513","DOI":"10.1038\/s41372-020-0652-y","volume":"40","author":"AL Elsaie","year":"2020","unstructured":"Elsaie AL et al (2020) Comparison of end-tidal carbon monoxide measurements with direct antiglobulin tests in the management of neonatal hyperbilirubinemia. J Perinatol 40(10):1513\u20131517","journal-title":"J Perinatol"},{"issue":"8","key":"4724_CR57","doi-asserted-by":"publisher","first-page":"1350","DOI":"10.1111\/apa.14316","volume":"107","author":"VK Bhutani","year":"2018","unstructured":"Bhutani VK et al (2018) Identification of risk for neonatal haemolysis. Acta Paediatr 107(8):1350\u20131356","journal-title":"Acta Paediatr"},{"issue":"5","key":"4724_CR58","doi-asserted-by":"publisher","first-page":"e189","DOI":"10.1111\/apa.13341","volume":"105","author":"VK Bhutani","year":"2016","unstructured":"Bhutani VK et al (2016) Identification of neonatal haemolysis: an approach to predischarge management of neonatal hyperbilirubinemia. Acta Paediatr 105(5):e189\u2013e194","journal-title":"Acta Paediatr"},{"issue":"2","key":"4724_CR59","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1542\/peds.2005-0395","volume":"117","author":"RP Wennberg","year":"2006","unstructured":"Wennberg RP et al (2006) Toward understanding kernicterus: a challenge to improve the management of jaundiced newborns. Pediatrics 117(2):474\u2013485","journal-title":"Pediatrics"},{"issue":"7","key":"4724_CR60","doi-asserted-by":"publisher","first-page":"1288","DOI":"10.1373\/clinchem.2008.121269","volume":"55","author":"CE Ahlfors","year":"2009","unstructured":"Ahlfors CE et al (2009) Unbound (free) bilirubin: improving the paradigm for evaluating neonatal jaundice. Clin Chem 55(7):1288\u20131299","journal-title":"Clin Chem"},{"issue":"5","key":"4724_CR61","doi-asserted-by":"publisher","first-page":"976","DOI":"10.1542\/peds.2007-2297","volume":"121","author":"CE Ahlfors","year":"2008","unstructured":"Ahlfors CE, Parker AE (2008) Unbound bilirubin concentration is associated with abnormal automated auditory brainstem response for jaundiced newborns. Pediatrics 121(5):976\u2013978","journal-title":"Pediatrics"},{"issue":"4","key":"4724_CR62","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1038\/jp.2008.199","volume":"29","author":"C Ahlfors","year":"2009","unstructured":"Ahlfors C, Amin S, Parker A (2009) Unbound bilirubin predicts abnormal automated auditory brainstem response in a diverse newborn population. J Perinatol 29(4):305\u2013309","journal-title":"J Perinatol"},{"issue":"5","key":"4724_CR63","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1111\/j.1651-2227.2010.01688.x","volume":"99","author":"W Oh","year":"2010","unstructured":"Oh W et al (2010) Influence of clinical status on the association between plasma total and unbound bilirubin and death or adverse neurodevelopmental outcomes in extremely low birth weight infants. Acta Paediatr 99(5):673\u2013678","journal-title":"Acta Paediatr"},{"issue":"8","key":"4724_CR64","doi-asserted-by":"publisher","first-page":"684","DOI":"10.1111\/ped.13635","volume":"60","author":"I Morioka","year":"2018","unstructured":"Morioka I (2018) Hyperbilirubinemia in preterm infants in Japan: new treatment criteria. Pediatr Int 60(8):684\u2013690","journal-title":"Pediatr Int"},{"key":"4724_CR65","unstructured":"Mailloux A et al (2008) Adaptation of a non-albumin-bound bilirubin test in the serum of newborns to the DxC 800 \u00ae Beckman Coulter. https:\/\/www.semanticscholar.org\/paper\/Adaptation-of-a-Non-Albumin-Bound-Bilirubin-test-in-Mailloux-Crayon\/2fd75787e91e736e6443bccddeb1256ffb6770be"},{"issue":"9","key":"4724_CR66","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1016\/j.clinbiochem.2014.05.043","volume":"47","author":"A Mailloux","year":"2014","unstructured":"Mailloux A (2014) What to expect from a bilirubin analysis for management of jaundiced newborns? Clin Biochem 47(9):751\u20132","journal-title":"Clin Biochem"},{"issue":"6","key":"4724_CR67","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0099466","volume":"9","author":"CV Hulzebos","year":"2014","unstructured":"Hulzebos CV et al (2014) The bilirubin albumin ratio in the management of hyperbilirubinemia in preterm infants to improve neurodevelopmental outcome: a randomized controlled trial \u2013 BARTrial. Plos One 9(6):e99466","journal-title":"PLOS ONE"},{"issue":"2","key":"4724_CR68","doi-asserted-by":"publisher","first-page":"E17","DOI":"10.1542\/peds.106.2.e17","volume":"106","author":"VK Bhutani","year":"2000","unstructured":"Bhutani VK et al (2000) Noninvasive measurement of total serum bilirubin in a multiracial predischarge newborn population to assess the risk of severe hyperbilirubinemia. Pediatrics 106(2):E17","journal-title":"Pediatrics"},{"issue":"6","key":"4724_CR69","doi-asserted-by":"publisher","first-page":"1628","DOI":"10.1542\/peds.113.6.1628","volume":"113","author":"MJ Maisels","year":"2004","unstructured":"Maisels MJ et al (2004) Evaluation of a new transcutaneous bilirubinometer. Pediatrics 113(6):1628\u201335","journal-title":"Pediatrics"},{"issue":"3","key":"4724_CR70","doi-asserted-by":"publisher","first-page":"266","DOI":"10.3122\/jabfm.2007.03.060172","volume":"20","author":"KB Kolman","year":"2007","unstructured":"Kolman KB, Mathieson KM, Frias C (2007) A comparison of transcutaneous and total serum bilirubin in newborn Hispanic infants at 35 or more weeks of gestation. J Am Board Fam Med 20(3):266\u201371","journal-title":"J Am Board Fam Med"},{"issue":"6","key":"4724_CR71","doi-asserted-by":"publisher","first-page":"1264","DOI":"10.1542\/peds.107.6.1264","volume":"107","author":"FF Rubaltelli","year":"2001","unstructured":"Rubaltelli FF et al (2001) Transcutaneous bilirubin measurement: a multicenter evaluation of a new device. Pediatrics 107(6):1264\u201371","journal-title":"Pediatrics"},{"key":"4724_CR72","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.jpeds.2020.08.079","volume":"228","author":"OS Konana","year":"2021","unstructured":"Konana OS et al (2021) Decision accuracy and safety of transcutaneous bilirubin screening at intermountain healthcare. J Pediatr 228:53\u201357","journal-title":"J Pediatr"},{"issue":"1","key":"4724_CR73","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1542\/peds.2011-0599","volume":"129","author":"S Wainer","year":"2012","unstructured":"Wainer S et al (2012) Impact of a transcutaneous bilirubinometry program on resource utilization and severe hyperbilirubinemia. Pediatrics 129(1):77\u201386","journal-title":"Pediatrics"},{"key":"4724_CR74","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1016\/j.earlhumdev.2016.10.005","volume":"103","author":"E Letamendia-Richard","year":"2016","unstructured":"Letamendia-Richard E et al (2016) Relationship between transcutaneous bilirubin and circulating unbound bilirubin in jaundiced neonates. Early Hum Dev 103:235\u2013239","journal-title":"Early Hum Dev"},{"key":"4724_CR75","doi-asserted-by":"crossref","unstructured":"Thayyil S, Milligan DW (2006) Single versus double volume exchange transfusion in jaundiced newborn infants. Cochrane Database Syst Rev (4):Cd004592","DOI":"10.1002\/14651858.CD004592.pub2"},{"issue":"3","key":"4724_CR76","first-page":"177","volume":"43","author":"M Amato","year":"1988","unstructured":"Amato M et al (1988) Effectiveness of single versus double volume exchange transfusion in newborn infants with AB0 hemolytic disease. Helv Paediatr Acta 43(3):177\u201386","journal-title":"Helv Paediatr Acta"},{"issue":"7","key":"4724_CR77","doi-asserted-by":"publisher","first-page":"1080","DOI":"10.3109\/14767058.2011.622008","volume":"25","author":"W Abbas","year":"2012","unstructured":"Abbas W, Attia NI, Hassanein SM (2012) Two-stage single-volume exchange transfusion in severe hemolytic disease of the newborn. J Matern Fetal Neonatal Med 25(7):1080\u20133","journal-title":"J Matern Fetal Neonatal Med"},{"key":"4724_CR78","doi-asserted-by":"crossref","unstructured":"Bhat YR (2007) Management of neonatal hyperbilirubinemia - what is the efficacy of exchange transfusion by different techniques? J Neonatol 21(1):68\u201370","DOI":"10.1177\/0973217920070116"},{"issue":"5","key":"4724_CR79","doi-asserted-by":"publisher","first-page":"820","DOI":"10.1016\/S0022-3476(79)80169-9","volume":"94","author":"N Campbell","year":"1979","unstructured":"Campbell N, Stewart I (1979) Exchange transfusion in ill newborn infants using peripheral arteries and veins. J Pediatr 94(5):820\u2013822","journal-title":"J Pediatr"},{"issue":"3","key":"4724_CR80","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1053\/j.semperi.2011.02.013","volume":"35","author":"S Murki","year":"2011","unstructured":"Murki S, Kumar P (2011) Blood exchange transfusion for infants with severe neonatal hyperbilirubinemia. Semin Perinatol 35(3):175\u2013184","journal-title":"Semin Perinatol"},{"issue":"9","key":"4724_CR81","doi-asserted-by":"publisher","first-page":"990","DOI":"10.1111\/vox.13090","volume":"116","author":"IMC Ree","year":"2021","unstructured":"Ree IMC et al (2021) Exchange transfusions in severe Rh-mediated alloimmune haemolytic disease of the foetus and newborn: a 20-year overview on the incidence, associated risks and outcome. Vox Sang 116(9):990\u2013997","journal-title":"Vox Sang"},{"issue":"1","key":"4724_CR82","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1542\/peds.2006-2910","volume":"120","author":"LA Steiner","year":"2007","unstructured":"Steiner LA et al (2007) A decline in the frequency of neonatal exchange transfusions and its Effect on exchange-related morbidity and mortality. Pediatrics 120(1):27\u201332","journal-title":"Pediatrics"},{"issue":"5","key":"4724_CR83","doi-asserted-by":"publisher","first-page":"E7","DOI":"10.1542\/peds.99.5.e7","volume":"99","author":"JC Jackson","year":"1997","unstructured":"Jackson JC (1997) Adverse events associated with exchange transfusion in healthy and ill newborns. Pediatrics 99(5):E7","journal-title":"Pediatrics"},{"issue":"10","key":"4724_CR84","doi-asserted-by":"publisher","first-page":"1506","DOI":"10.1038\/s41372-020-0642-0","volume":"40","author":"MF Wolf","year":"2020","unstructured":"Wolf MF et al (2020) Exchange transfusion safety and outcomes in neonatal hyperbilirubinemia. J Perinatol 40(10):1506\u20131512","journal-title":"J Perinatol"},{"key":"4724_CR85","doi-asserted-by":"publisher","unstructured":"Jansen SJ, Ree IMC, Broer L, de Winter D, de Haas M, Bekker V, Lopriore E (2022) Neonatal sepsis in alloimmune hemolytic disease of the fetus and newborn: A retrospective cohort study of 260 neonates. Transfusion. Advance online publication. https:\/\/doi.org\/10.1111\/trf.17176; https:\/\/pubmed.ncbi.nlm.nih.gov\/36334304\/","DOI":"10.1111\/trf.17176"},{"issue":"5","key":"4724_CR86","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1136\/archdischild-2021-322891","volume":"107","author":"BAM van der Geest","year":"2022","unstructured":"Van der Geest BAM et al (2022) Severe neonatal hyperbilirubinaemia: lessons learnt from a national perinatal audit. Arch Dis Child Fetal Neonatal Ed 107(5):527\u2013532","journal-title":"Arch Dis Child Fetal Neonatal Ed"},{"key":"4724_CR87","doi-asserted-by":"crossref","unstructured":"Zwiers C et al (2018) Immunoglobulin for alloimmune hemolytic disease in neonates. Cochrane Database Syst Rev\u00a03(3):Cd003313","DOI":"10.1002\/14651858.CD003313.pub2"},{"issue":"4","key":"4724_CR88","doi-asserted-by":"publisher","first-page":"680","DOI":"10.1542\/peds.2010-3242","volume":"127","author":"VEHJ Smits-Wintjens","year":"2011","unstructured":"Smits-Wintjens VEHJ et al (2011) Intravenous immunoglobulin in neonates with Rhesus hemolytic disease: a randomized controlled trial. Pediatrics 127(4):680\u2013686","journal-title":"Pediatrics"},{"issue":"4","key":"4724_CR89","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1111\/j.1537-2995.2012.03827.x","volume":"53","author":"MC Santos","year":"2013","unstructured":"Santos MC et al (2013) The efficacy of the use of intravenous human immunoglobulin in Brazilian newborns with Rhesus hemolytic disease: a randomized double-blind trial. Transfusion 53(4):777\u2013782","journal-title":"Transfusion"},{"key":"4724_CR90","unstructured":"Garcia M et al (2004)\u00a0Intravenous immunoglobulin (IVIG) administration as a treatment for Rh hemolytic jaundice in Mexico City. in Pediatric Research. Int Pediatric Research Foundation,\u00a0Inc 351 West Camden St,\u00a0Baltimore\u00a0MD.\u00a0https:\/\/www.cochranelibrary.com\/es\/central\/doi\/10.1002\/central\/CN-00526720\/full"},{"issue":"4","key":"4724_CR91","doi-asserted-by":"publisher","first-page":"F325","DOI":"10.1136\/archdischild-2013-304878","volume":"99","author":"D Louis","year":"2014","unstructured":"Louis D et al (2014) Intravenous immunoglobulin in isoimmune haemolytic disease of newborn: an updated systematic review and meta-analysis. Arch Dis Child Fetal Neonatal Ed 99(4):F325\u201331","journal-title":"Arch Dis Child Fetal Neonatal Ed"},{"issue":"1","key":"4724_CR92","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1111\/bjh.18170","volume":"198","author":"L Lieberman","year":"2022","unstructured":"Lieberman L et al (2022) International guidelines regarding the role of IVIG in the management of Rh- and ABO-mediated haemolytic disease of the newborn. Br J Haematol 198(1):183\u2013195","journal-title":"Br J Haematol"},{"issue":"7","key":"4724_CR93","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1080\/17474086.2017.1331124","volume":"10","author":"IMC Ree","year":"2017","unstructured":"Ree IMC et al (2017) Neonatal management and outcome in alloimmune hemolytic disease. Expert Rev Hematol 10(7):607\u2013616","journal-title":"Expert Rev Hematol"},{"issue":"4","key":"4724_CR94","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1111\/bjh.15962","volume":"186","author":"IMC Ree","year":"2019","unstructured":"Ree IMC et al (2019) Predicting anaemia and transfusion dependency in severe alloimmune haemolytic disease of the fetus and newborn in the first 3 months after birth. Br J Haematol 186(4):565\u2013573","journal-title":"Br J Haematol"},{"issue":"4","key":"4724_CR95","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1111\/vox.12061","volume":"105","author":"MEA Rath","year":"2013","unstructured":"Rath MEA et al (2013) Iron status in infants with alloimmune haemolytic disease in the first three months of life. Vox Sang 105(4):328\u2013333","journal-title":"Vox Sang"},{"issue":"3","key":"4724_CR96","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1056\/NEJMoa1807320","volume":"380","author":"A Curley","year":"2019","unstructured":"Curley A et al (2019) Randomized trial of platelet-transfusion thresholds in neonates. N Engl J Med 380(3):242\u2013251","journal-title":"N Engl J Med"},{"issue":"4","key":"4724_CR97","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1159\/000335333","volume":"101","author":"VE Smits-Wintjens","year":"2012","unstructured":"Smits-Wintjens VE et al (2012) Cholestasis in neonates with red cell alloimmune hemolytic disease: incidence, risk factors and outcome. Neonatology 101(4):306\u201310","journal-title":"Neonatology"},{"issue":"3","key":"4724_CR98","first-page":"199","volume":"13","author":"JB Le Pichon","year":"2017","unstructured":"Le Pichon JB et al (2017) The neurological sequelae of neonatal hyperbilirubinemia: definitions, diagnosis and treatment of the kernicterus spectrum disorders (KSDs). Curr Pediatr Rev 13(3):199\u2013209","journal-title":"Curr Pediatr Rev"},{"key":"4724_CR99","doi-asserted-by":"crossref","unstructured":"Das S, Van Landeghem FKH (2019) Clinicopathological spectrum of bilirubin encephalopathy\/kernicterus. Diagnostics (Basel)\u00a09(1)","DOI":"10.3390\/diagnostics9010024"},{"issue":"1","key":"4724_CR100","doi-asserted-by":"publisher","first-page":"S20","DOI":"10.1038\/jp.2008.212","volume":"29","author":"VK Bhutani","year":"2009","unstructured":"Bhutani VK, Johnson L (2009) Kernicterus in the 21st century: frequently asked questions. J Perinatol 29(1):S20\u2013S24","journal-title":"J Perinatol"},{"key":"4724_CR101","doi-asserted-by":"publisher","first-page":"105381","DOI":"10.1016\/j.earlhumdev.2021.105381","volume":"157","author":"IMC Ree","year":"2021","unstructured":"Ree IMC et al (2021) School performance and behavioral functioning in children after intrauterine transfusions for hemolytic disease of the fetus and newborn. Early Hum Dev 157:105381","journal-title":"Early Hum Dev"},{"issue":"3","key":"4724_CR102","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1159\/000434718","volume":"39","author":"JM Van Klink","year":"2016","unstructured":"Van Klink JM et al (2016) Immunoglobulins in neonates with Rhesus hemolytic disease of the fetus and newborn: long-term outcome in a randomized trial. Fetal Diagn Ther 39(3):209\u201313","journal-title":"Fetal Diagn Ther"},{"key":"4724_CR103","doi-asserted-by":"crossref","unstructured":"Bhutani VK et al (2013) Neonatal hyperbilirubinemia and Rhesus disease of the newborn: incidence and impairment estimates for 2010 at regional and global levels. Pediatr Res\u00a074 Suppl 1(Suppl 1):86\u2013100","DOI":"10.1038\/pr.2013.208"}],"container-title":["European Journal of Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00431-022-04724-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00431-022-04724-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00431-022-04724-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,12,2]],"date-time":"2023-12-02T07:56:54Z","timestamp":1701503814000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00431-022-04724-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12,5]]},"references-count":103,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2023,2]]}},"alternative-id":["4724"],"URL":"https:\/\/doi.org\/10.1007\/s00431-022-04724-0","relation":{},"ISSN":["1432-1076"],"issn-type":[{"value":"1432-1076","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,12,5]]},"assertion":[{"value":"17 October 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 November 2022","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 November 2022","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 December 2022","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Not applicable","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Not applicable","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Derek P. de Winter, PhD candidate, is funded by Momenta Pharmaceuticals, Inc., which was acquired by Johnson & Johnson, and is a coordinating investigator for a phase 2 trial (NCT03842189) of a new drug for the treatment of HDFN, which is sponsored by Janssen Pharmaceuticals.\u00a0Renske M van \u2018t Oever is a coordinating investigator for a phase 2 trial (NCT03842189) of a new drug for the treatment of HDFN, which is sponsored by Janssen Pharmaceuticals.\u00a0Joanne EJT Verweij is the principal investigator for a phase 2 trial (NCT03842189) of a new drug for the treatment of HDFN, which is sponsored by Janssen Pharmaceuticals.\u00a0Enrico Lopriore is a sub-investigator for a phase 2 trial (NCT03842189) of a new drug for the treatment of HDFN, which is sponsored by Janssen Pharmaceuticals.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}